Liraglutide Attenuates Diabetic Cardiomyopathy Via The ILK/PI3K/Akt Signaling Pathway In Streptozotocin-Induced Type 2 Diabetes Mellitus In Rats

Presented by:
Shatha Majed Alobaid
Rahaf Mastour Alshahrani
Supervised by:
Prof. Nouf Alrasheed
Dr. Asma Alonazi